Case Report: Long-Acting Oral Cariprazine

INTRODUCTION: Cariprazine is a third-generation antipsychotic, approved for the treatment of schizophrenia and bipolar disorder and used off-label for schizoaffective disorder and treatment-resistant depression. Cariprazine is a partial agonist at dopamine receptors D2 and D3 and serotonin receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyrmishi, Emanuela, De Pieri, Marco, Ferrari, Marco, Traber, Rafael, Preve, Matteo, De Peri, Luca, Bolla, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093047/
https://www.ncbi.nlm.nih.gov/pubmed/35573352
http://dx.doi.org/10.3389/fpsyt.2022.876003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093047/
https://www.ncbi.nlm.nih.gov/pubmed/35573352
http://dx.doi.org/10.3389/fpsyt.2022.876003

Ejemplares similares